Skip to main content
Log in

The effects of phenylmethanesulfonyl fluoride on delayed organophosphorus neuropathy

  • Original Investigations
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

A delayed localized neuropathy of peripheral nerves in a single hind leg of the cat develops after a single intraarterial 2 mg/kg injection of diisopropylfluorophosphate (DFP). This neuropathy is manifested by a maximum loss of the capacity of soleus α-motor nerve terminals to generate stimulus-bound repetition 21 days after DFP exposure. Phenylmethanesulfonyl fluoride (PMSF) is a protective inhibitor of the neurotoxic esterase which is associated with the development of the delayed organophosphorus neuropathy. Pretreatment of cats with PMSF (30 mg/kg i.p.) 24 h before the DFP injection protected the cats from the delayed neuropathy. No clinical neurotoxic signs were observed at 21 days after DFP. The stimulus-bound repetitive capacity of soleus α-motor nerve terminals was not lost at this time and its incidence was much greater than that which occurred in cats not pretreated with PMSF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Baker T, Lowndes HE (1980) Muscle spindle function in organophosphorus neuropathy. Brain Res 185: 77–84

    Google Scholar 

  • Baker T, Glazer E, Lowndes HE (1977a) Subacute neuropathic effects of diisopropylfluorophos-phate at the cat soleus neuromuscular junction. Neuropathol Appl Neurobiol 3: 377–390

    Google Scholar 

  • Baker T, Riker WF Jr, Hall ED (1977b) Effects of a single methylprednisolone dose on a facilitatory response of mammalian motor nerve. Arch Neurol 34: 349–355

    Google Scholar 

  • Baker T, Lowndes HE, Johnson MK (1980) Phenylmethylsulfonyl fluoride protection in delayed organophosphorus neuropathy. Fed Proc 39: 416

    Google Scholar 

  • Bouldin TW, Cavanagh JB (1979a) Organophosphorus neuropathy. I. A teased fiber study of the spatio-temporal spread of axonal degeneration. Am J Pathol 94: 241–252

    Google Scholar 

  • Bouldin TW, Cavanagh JB (1979b) Organophosphorus neuropathy. II. A fine-structural study of the early stages of axonal degeneration. Am J Pathol 94: 253–271

    Google Scholar 

  • Glazer EJ, Baker T, Riker WF Jr (1978) The neuropathology of DFP at cat soleus neuromuscular junction. J Neurotycol 7: 741–758

    Google Scholar 

  • Howland RD, Lowndes HE, Baker T, Richardson RJ (1980) DFP mononeuropathy. evidence for a peripheral site of initiation. Brain Res 184: 248–251

    Google Scholar 

  • James KAC, Austin L (1970) The effect of DFP on axonal transport of protein in chicken sciatic nerve. Brain Res 18: 192–194

    Google Scholar 

  • Johnson MK (1969) A phosphorylation site in brain and the delayed neurotoxid effect of some organophosphorus compounds. Biochem J 111: 487–495

    Google Scholar 

  • Johnson MK (1970) Organophosphorus and other inhibitors of brain neurotoxic esterase and the development of delayed neurotoxicity in hens. Biochem J 120: 523–531

    Google Scholar 

  • Johnson MK (1975a) The delayed neuropathy caused by some organophosphorus esters: mechanism and challenge. CRC Crit Rev Toxicol 3: 289–316

    Google Scholar 

  • Johnson MK (1975b) Organophosphorus esters causing delayed neurotoxic effects. Arch Toxicol 34: 259–288

    Google Scholar 

  • Lotti M, Johnson MK (1980) Neurotoxic esterase in human nervous tissue. J Neurochem 34: 747–749

    Google Scholar 

  • Lowndes HE, Baker T (1976) Studies on drug-induced neuropathies. III. Motor nerve deficit in cats with acrylamide neuropathy. Eur J Pharmacol 35: 177–184

    Google Scholar 

  • Lowndes HE, Baker T (1980) Toxic site of action in distal axonopathies. In: Spenser PC, Schaumberg HH (eds), Experimental and clinical neurotoxicology. Williams and Wilkins, Baltimore, p 193

    Google Scholar 

  • Lowndes HE, Baker T, Riker WF Jr (1974) Motor nerve dysfunction in delayed DFP neuropathy. Eur J Pharmacol 29: 66–73

    Google Scholar 

  • Lowndes HE, Baker T, Riker WF Jr (1975) Motor nerve terminal response to edrophonium in delayed DFP neuropathy. Eur J Pharmacol 30: 69–72

    Google Scholar 

  • Okamoto M, Riker WF Jr (1969) Motor nerve terminals as the site of initial functional changes after denervation. J Gen Physiol 53: 70–80

    Google Scholar 

  • Riker WF Jr, Baker T, Okamoto M (1975) Glucocorticoids and mammalian motor nerve excitability. Arch Neurol 32: 688–694

    Google Scholar 

  • Standaert FG (1963) Post-tetanic repetitive activity in the cat soleus nerve. J Gen Physiol 47: 53–67

    Google Scholar 

  • Standaert FG (1964) The mechanisms of post-tetanic potentiation in cat soleus and gastrocnemius muscles. J Gen Physiol 47: 987–1001

    Google Scholar 

  • Vincent-Ablazey M, Baker T, Lowndes HE (1978) Motor nerve terminal defect following tenotomy. Experientia 34: 1479–1480

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was supported by U.S. Public Health Service National Institute for Neurological and Communicative Diseases and Stroke Grants NS-01447 and NS-11948

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baker, T., Lowndes, H.E., Johnson, M.K. et al. The effects of phenylmethanesulfonyl fluoride on delayed organophosphorus neuropathy. Arch Toxicol 46, 305–311 (1980). https://doi.org/10.1007/BF00310448

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00310448

Key words

Navigation